As Vice President of Stakeholder Management & Patient Advocacy at Otsuka America Pharmaceutical, Inc. (OAPI), Mary has the unique opportunity to work with trailblazing leaders both inside and outside the clinic walls to create innovative patient-centered solutions. It is her responsibility to understand how the world is changing across multiple disease categories, and she pulls together the thoughts, ideas, and research from a global array of key opinion leaders, patient advocates, technologists, caregivers, and others to incubate novel business solutions. Mary brings innovation to Otsuka by engaging with stakeholders from the world’s most prestigious medical centers as well as local advocacy chapters.
Before coming to Otsuka, Mary spent nine years with Wyeth in Opinion Leader and Advocacy Relations, where she developed and executed their global opinion leader business strategies across the specialty products portfolio. Prior to Wyeth, she was with Bristol-Myers Squibb for 13 years in a variety of positions. At Otsuka, Mary has spearheaded the launch of the Global Council on Alzheimer’s Disease (GCAD), a collection of preeminent experts who influence the Alzheimer’s space, including science, medicine, technology, policy, advocacy, and caregiving. Through GCAD, she has jumpstarted technological innovation, framed a patient navigation model for Alzheimer’s disease, and helped improve communication between families and healthcare providers.
Mary is a graduate of both Virginia Tech and Singularity University.
[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]